Jaguar Health Inc.

NASDAQ: JAGX · Real-Time Price · USD
2.08
0.01 (0.48%)
At close: Aug 15, 2025, 3:59 PM
2.12
1.68%
After-hours: Aug 15, 2025, 07:45 PM EDT

Jaguar Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
11.51M 11.69M 10.48M 10.19M 10.14M 9.76M 10.72M 11.06M 11.3M 11.96M 10.78M 8.26M 5.72M 4.34M 4.83M 6.97M 9.76M
Cost of Revenue
2.04M 2.56M 3.29M 3.26M 3.32M 2.63M 1.84M 1.94M 1.91M 2.02M 1.99M 2M 2.21M 2.33M 2.65M 2.82M 3.19M
Gross Profit
9.47M 9.12M 7.19M 6.93M 6.82M 7.13M 8.88M 9.11M 9.39M 9.94M 8.78M 6.26M 3.52M 2M 2.18M 4.16M 6.57M
Operating Income
-32.04M -30.83M -29.86M -31.39M -32.29M -33.92M -33.02M -34.13M -32.51M -34.41M -38.95M -38.58M -43.69M -40.7M -35.04M -30.89M -27.76M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-40.48M -39.25M -38.33M -36.21M -38.87M -41.9M -40.82M -45.53M -42.63M -48.4M -54.48M -54.06M -58.76M -52.6M -47.05M -42.73M -37.88M
Net Income
-39.73M -38.49M -37.74M -35.67M -38.32M -41.3M -39.51M -44.25M -41.47M -47.25M -54.19M -53.86M -58.57M -52.59M -47.05M -42.73M -37.88M
Selling & General & Admin
25.59M 24.02M 22.19M 21.41M 21.58M 22.46M 22.45M 23.94M 24.42M 26.7M 28.92M 28.65M 29.42M 25.99M 24.09M 23.7M 21.93M
Research & Development
15.96M 16.54M 15.47M 17.51M 18.13M 18.6M 19.44M 19.3M 17.48M 17.65M 18.82M 16.19M 17.61M 15.08M 11.5M 9.71M 7.25M
Other Expenses
n/a 234K 234K 164K 190K -56K -56K 14K -12K n/a n/a -20K -37K -27K -27K -7K 10K
Operating Expenses
41.55M 39.95M 37.05M 38.31M 39.11M 41.05M 41.9M 43.24M 41.9M 44.35M 47.73M 44.84M 47.03M 41.07M 35.59M 33.41M 29.17M
Interest Expense
56K 611K 859K 1.36M 4.81M 6.38M 8.77M 11M 10.08M 12.1M 11.89M 11.24M 10.71M 8.42M 7.52M 6.02M 4.49M
Selling & Marketing Expenses
7.57M 5.74M 5.73M 4.35M 3.71M 4.93M 5.15M 6.62M 7.08M 8.03M 8.58M 8.73M 9.59M 8.89M 8.47M 7.74M 7.28M
Cost & Expenses
43.59M 42.52M 40.34M 41.57M 42.43M 43.68M 43.74M 45.19M 43.81M 46.37M 49.73M 46.84M 49.23M 43.4M 38.24M 36.23M 32.36M
Income Tax Expense
-132K n/a -139K -139K -139K -139K -852K -941K -964K -1.14M -295K -206K -183K -5K n/a n/a n/a
Shares Outstanding (Basic)
626.64K 294.53K 374.81K 93.98K 1.77K 15.42K 13.86K 11.79K 3.42K 11.69 12.64 9.52 6.93 5.45 5.36 1.77 1.66
Shares Outstanding (Diluted)
626.64K 294.53K 374.81K 93.98K 1.77K 15.42K 13.86K 19.46K 3.42K 11.69 12.64 9.52 6.93 5.45 5.45 1.78 1.69
EPS (Basic)
-177.63 -5.38K -5.95K -6.49K -7.42K -5.79K -638.57K -1.63M -2.62M -5.21M -7.21M -8.5M -15.47M -20.14M -34.74M -47.31M -68.72M
EPS (Diluted)
-177.63 -5.38K -5.95K -6.49K -7.02K -5.38K -638.16K -1.63M -2.62M -5.21M -7.21M -8.46M -15.39M -19.92M -34.52M -47.13M -68.58M
EBITDA
-38.48M -37.2M -29.92M -30.03M -30.88M -32.4M -28.92M -31.43M -30.16M -34.01M -41.18M -41.53M -46.97M -43.13M -37.76M -34.79M -31.6M
EBIT
-30.8M -39.56M -30.4M -30.54M -31.45M -32.91M -31.32M -33.79M -32.55M -36.3M -42.59M -42.82M -48.04M -44.18M -39.53M -36.7M -33.39M
Depreciation & Amortization
1.75M 2.36M 2.36M 2.38M 2.45M 2.39M 2.4M 2.36M 2.39M 2.29M 2.18M 2.07M 1.85M 1.83M 1.77M 1.91M 2.09M